VASORX
VasoRx is developing RNA therapies for diseases of the cardiovascular VasoRx is leading the translation of technologies discovered at Massachusetts Institute of Technology (M.I.T) and Yale for the delivery of RNAs for the treatment of diseases. With the world’s first approved RNAi therapeutic, the field of RNA medicines is rapidly expanding. VasoRx utilizes novel nanoparticles that are dramatically expanding the opportunities for developing RNA therapies for diseases of the cardiovascular system as well as oncology. system & oncology such as atherosclerosis and pulmonary hypertension.
VASORX
Industry:
Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
Santa Barbara, California, United States
Country:
United States
Website Url:
http://www.vasrx.com
Total Employee:
1+
Status:
Active
Contact:
(619) 889-5199
Total Funding:
1.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Font Awesome Wordpress Plugins Mobile Non Scaleable Content Euro
Similar Organizations
ZS Pharma
ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.vasrx.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "VasoRx" on Search Engine
Team 1 — VasoRX
Chair of Scientific Advisory Board, Founder of VasoRx. Robert S. Langer is one of 11 Institute Professors at MIT. Dr. Langer has written more than 1,570 articles. He also has over 1,400 issued and pending patents …See details»
VasoRx - Crunchbase Company Profile & Funding
Biotechnology. Oncology. Pharmaceutical. Headquarters Regions West Coast, Western US. Founded Date 2018. Founders Daniel Anderson, Krisztina Zsebo, Michael Simons, …See details»
VasoRx Company Profile: Valuation, Funding & Investors
Apr 1, 2018 1. General Information. Description. Developer of RNA (Ribonucleic acid) therapies for diseases of the cardiovascular system as well as oncology.See details»
VasoRx Company Profile - Office Locations, Competitors, …
VasoRx is a pharmaceutical company developing RNA therapies for diseases of the cardiovascular system as well as oncology. Its nanoparticles are made of low molecular …See details»
VasoRx - Funding, Financials, Valuation & Investors - Crunchbase
VasoRx has raised a total of. $7.2M. in funding over 2 rounds. Their latest funding was raised on Nov 1, 2020 from a Grant round. VasoRx is funded by Good Ventures. Unlock …See details»
VasoRX — Atherosclerosis Investment | Open Philanthropy
VasoRX — Atherosclerosis Investment. Portfolio Area: Human Health and Wellbeing. Focus Area: Scientific Research. Organization Name: VasoRX. Amount: $5,400,000. …See details»
Krisztina Zsebo - Co-Founder, Chief Executive Officer, and …
Krisztina Zsebo. Summary. Overview. Number of Founded Organizations 1. CB Rank (Investor) 104,000. Primary Job Title Co-Founder, Chief Executive Officer, and …See details»
VasoRx - Org Chart, Teams, Culture & Jobs | The Org
View VasoRx's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
VasoRX — Atherosclerosis and Pulmonary Arterial Hypertension …
VasoRX — Atherosclerosis and Pulmonary Arterial Hypertension Therapy. Visit Grantee Site. Portfolio Area: Human Health and Wellbeing. Focus Area: Scientific Research. …See details»
MIT community members elected to the National Academy of …
Jan 3, 2024 He has founded several companies, including Living Proof, Olivo Labs, Crispr Therapeutics (CRSP), Sigilon Therapeutics, Verseau Therapeutics, oRNA, and VasoRx. …See details»
VasoRx, Inc. | VentureRadar
Location: USA. Founded in 2018. Private Company. Develops RNA-based therapies for cardiovascular diseases and oncology using novel nanoparticles, originating from MIT …See details»
VasoRx develops patent portfolios relating to lipid nanoparticles …
Share. VasoRx develops patent portfolios relating to lipid nanoparticles for RNA-based therapies. April 2023. Client (s) VasoRX, Inc.See details»
VasoRx - Contacts, Employees, Board Members, Advisors
Organization. VasoRx. Connect to CRM. Save. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 4. About. VasoRx …See details»
VasoRx | CipherBio
Explore VasoRx's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Grant - VasoRx - 2020-11-01 - Crunchbase Funding Round Profile
Nov 1, 2020 Organization Name . VasoRx . Announced Date Nov 1, 2020; Funding Type ...See details»
Services 2 — VasoRX
We are developing an IV formulation of LNPs that target and specifically reprogram coronary vascular cells (heart vasculature endothelial cells) and carotid vascular …See details»
VasoRx - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. VasoRx. Connect to CRM. Save. Summary Financials People Technology Signals & News Similar Companies. Highlights. Active Tech Count 18. About. VasoRx is …See details»
VasoRx - Crunchbase
Companies like VasoRx include Excision BioTherapeutics, Geneos Therapeutics, and VintaBio. Iroko Pharmaceuticals Philadelphia , Pennsylvania , United States 34 Contacts …See details»